ASLAN Pharmaceuticals Ltd (ASLN) Options

ASLN: "Spectacular" results!! (Big news!!)

Repeat performance

Atopic dermatitis
Also called: eczema

.70

https://www.globenewswire.com/news-release/2024/04/22/2866887/0/en/ASLAN-Pharmaceuticals-Announces-Positive-Interim-Results-From-Phase-2-Study-of-Eblasakimab-in-Dupilumab-Experienced-Atopic-Dermatitis-Patients.html

Up off the mat
https://ih.advfn.com/markets/nasdaq/premarket

Pop

ASLN....................................https://stockcharts.com/h-sc/ui?s=ASLN&p=W&b=5&g=0&id=p86431144783

$ASLN OFFERING ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering $ASLN https://t.co/azphKtx8yg— Health Stocks News (@health_stocks) March 12, 2024

ALL OUT...DILUTION KICKING IN NOW

ASLN..INDICATORS POINTING UP AND UP

ASLN..THIS LITTLE BIO BITCH IS GOING TO SMACK SOME ASK!!

ASLN...BIO BEAST

Still going damn

10$ pm or what

Someone buying a boat load

Finally!!

ASLN new 52 week low

ASLN new 52 week low

ASLN new 52 week low

ASLN new 52 week low

ASLN new 52 week low

Volume

90.2 million cash on hand.

But $2.30 is nicer!!!

$3.64 nice

* * $ASLN Video Chart 03-01-2021 * *

Link to Video - click here to watch the technical chart video

$ASLC - $HRVSF - $UA - $SLV

ASLN Pre-Market $7.62 +3.19 (+72.01%)

ASLAN Pharmaceuticals reports positive data from three dose cohorts for study of ASLAN004 for the treatment of moderate to severe atopic dermatitis

6:09 AM ET 3/1/21 | Briefing.com

Co announces positive interim unblinded data from the three dose cohorts of its ongoing randomised, double-blind placebo controlled multiple ascending dose study of ASLAN004 for the treatment of moderate to severe atopic dermatitis. ASLAN004 was shown to be well tolerated across all doses and showed improvements compared to placebo in all efficacy endpoints, supporting its potential as a differentiated, novel treatment for AD.The Phase 1 study evaluated three doses of ASLAN004 (200mg, 400mg and 600mg) delivered subcutaneously and is now recruiting a fourth (expansion) cohort (600mg).The average baseline Eczema Area Severity Index score of patients was 32.5 and the average Investigators Global Assessment score was 3.4.At week 8, the average reduction in EASI from baseline at therapeutic doses (400mg and 600mg cohorts) was 74% compared to 42% for patients on placebo.Peak pruritus improved after just one dose and continued to improve by an average of 46% relative to baseline at 8 weeks compared to 16% for patients on placebo.

* * $ASLN Video Chart 02-25-2021 * *

Link to Video - click here to watch the technical chart video

AGREED

$5.30 next leg up :)

$4.70 nice

Confidential treatment order ????

Something going on here last night traded up to $2.23 after hours opened up down today and now up .... expecting news

No selling , typical suck out with a .04 cent spread

Started a position

Sweet day here. Woke up and my $4s were sold. glta

Mm Making a New inhibitor For MS.

What is the news?

Buy In?I Might

ASLN Bullish cross of the 50/200sma Yesterday!

Slowly climbing. glta

LMFAOO...flipping through my Portland saw that this train wreck is up huge Sold some that got close to $1 and keeping the rest. Amazing stuff...

These stupid sellers could not have been able to ransomware ASLN if the dumb Market makers are not complicit!!! Fools will covet higher regardless.

Lol...idiots gave up sitting on this one. Thanks fos for the $1.77 adds. Holding now for my $4 target!!! Lol again for these fools.

Loaded. HUGE on this one today. The MMs are frankly zombies....we will see how I don't do $6 on my shares. We did same on another name earlier and we hit my numbers. The bet is on....$5-$6 here.

Still cracking up at the fools that make market on this one...I mean so-called market makers. Just gamblers! Cramer says: "They Know Nothing!" I agree...100 percent.

This stock...ASLN has turned out to be the Grand Canyon and Epicenter of MM manipulation of the MARKET. That won't be for long!!! Watch out!

How about putting some Market Manipulators in jail...MMs in jail??? Would be fantastic!!!

Manipulative conduct is often divided into two categories: “Traditional Manipulation” and “Open Market Manipulation.” Traditional manipulation requires a “bad act” explicitly proscribed under Section 9(a)(1) of the Exchange Act, such as fictitious trading, a “pump and dump” scheme, or wash sales. Under Rule 10b-5, the fraudulent conduct alone is indicative of the manipulator’s deceptive intent. In open market manipulation, the trades themselves are not objectively fraudulent but, when taken in context, may constitute a manipulative practice. An example is “painting the tape,” or “marking the close,” which involve engaging in a series of transactions on a public facility, typically at the end of a trading day, in order to give the impression of activity or price movement in a security. Each transaction may individually appear legitimate, making the manipulator’s intent in the overall open market scheme more difficult to prove.

Enforcement agencies have sought to target market manipulation as far back as 1934 when the Exchange Act was enacted. 

Hilarious watching MMs and other fools pushing the stock under $2 because it's one of my contest names. But I will sell ASLN $5 or higher sometime this year..... GUARANTEED!!!